Cureous Labs has secured ₹1.66 crore in seed funding led by Inflection Point Ventures, with Anthill Ventures participating, to manufacture its automated patient repositioning system Eturnal, build inventory, and expand operations. Founded by Biodesign Fellow Asish Mohandas, it develops affordable tech to prevent bedsores and ease caregiver strain, targeting India’s growing long-term care market.